Drreddys Laboratories reported INR16.37B in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Bayer EUR -399M 363M Sep/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Cipla INR 9.77B 6.21B Dec/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Drreddys Laboratories INR 16.37B 3.5B Dec/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 673M 54M Jun/2025
Novartis USD -9.19B 13.87B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Prestige Brands USD 79.67M 7.91M Sep/2025
Richter Gedeon HUF 63.58B 6.08B Sep/2025
Sun Pharmaceuticals INR 40.62B 6.95B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025